Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Advanced Cancers
Related studies linked through entity extraction aliases.
Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain
- Status
- COMPLETED
- Phase
- PHASE4
Genomic Profiling Assay in Phase I
- Status
- COMPLETED
- Phase
- N/A
Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention
- Status
- COMPLETED
- Phase
- NA
Cordotomy for Refractory Cancer Pain
- Status
- COMPLETED
- Phase
- NA
Rational Therapeutics Based on Matched Tumor and Normal Tissue
- Status
- COMPLETED
- Phase
- N/A
A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1
Profile Related Evidence to Determine Individualized Cancer Therapy (PREDICT) Program in Advanced Cancer Patients
- Status
- UNKNOWN
- Phase
- N/A
Personalized Oncogenomics (POG) Program of British Columbia
- Status
- RECRUITING
- Phase
- NA
Regorafenib and Cetuximab in Patients With Advanced Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
- Status
- TERMINATED
- Phase
- PHASE3
Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Fentanyl Buccal Tablets for Exercise Induced Breakthrough Dyspnea
- Status
- COMPLETED
- Phase
- PHASE2
Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab and Lenalidomide in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib and Crizotinib in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Dexamethasone Dyspnea Study
- Status
- COMPLETED
- Phase
- PHASE2